• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Innovation Partners

Innovation Partners

Healthcare Access Simplified

  • Home
  • About
  • Services
    • Payor and Market Access
    • Corporate and Patient Advocacy
    • Research and Forecasting
    • Healthcare Policy
    • Corporate Partnerships
  • Our Team
  • Our Partners
  • BioBlog
  • Contact
    • Get In Touch
    • Please Join Our Panel
    • Join Our Team
  • Community
    • Bridge 4 Hope

BioBlog

Innovation Partners Weekly BioBlog June 7

June 7, 2020

Highlights from the World of Cancer Care

ASCO’s conference, the 2020 Community Oncology Alliance Annual Conference, and other meets continue apace despite the COVID-19 pandemic. Conferences that have moved online are now presenting their findings virtually. Among them are a leadership panel addressing issues in cancer care, ASCO’s annual

BioBlog

Innovation Partners Weekly BioBlog

May 31, 2020

Merck Working on Potential COVID-19 Vaccine, More

In this weeks' Innovation Partners BioBlog, experts share opinions on how the healthcare industry will change after the first wave of the COVID-19 crisis passes. CVS plans to open more testing centers and hopefully process 1.5 million tests per month, depending on laboratories and supplies. And

BioBlog

Innovation Partners Weekly Curated BioBlog

May 24, 2020

Updates from the Oncology World

This week, several advances in the oncology world brought new hope to patients suffering from lung and pancreatic cancer. Roche’s Tecentriq gained new first-line lung cancer use while a Roswell Park Team developed a two-pronged approach to pancreatic cancer that offers promise. Oncologists received

BioBlog

Innovation Partners Weekly Curated Bioblog

May 17, 2020

New COVID-19 Therapy Studies, Lung Cancer Genetic Risk, and More

A two-combo cancer therapy has received FDA authorization for clinical researchers at a cancer center to begin a safety and effectiveness study. New data may have identified a genetic risk for lung cancer. The Trump Administration earmarked more money for states to conduct additional COVID-19

BioBlog

Innovation Partners Weekly Curated BioBlog May 10 edition

May 9, 2020

Everything Old Is New Again: Testing Older Drugs in the Fight Against COVID-19

Many pharmaceutical companies are testing and repurposing older medications to battle COVID-19. The lengthy list includes beta-blockers, drugs to combat autoimmune diseases, and stem cell therapy. The FDA issued emergency clearance for Gilead’s remdesivir to be used in hospital patients with

BioBlog

Innovation Partners Weekly BioBlog May 3 2020

May 3, 2020

Testing and Medications to Fight COVID-19

In this week’s Innovation Partners BioBlog, we sum up the week’s news about the many changes the healthcare industry is undergoing during the COVID-19 pandemic. The drive to reopen the United States economy will start in pharmacies as more pledge to increase access to COVID-19 tests. Organizations

BioBlog

Innovation Partners Weekly BioBlog April 26

April 24, 2020

Cancer Drug Updates in the News

In this week’s edition of the Innovation Partners BioBlog, we focus on updates from the world of cancer treatments. Despite many companies halting tests and clinical trials due to the COVID-19 pandemic, a few are reporting clinical trial results and the FDA has approved a treatment for advanced

BioBlog

Innovation Partners Curated BioBlog week of April 19, 2020

April 18, 2020

Cancer Care in the Era of COVID-19

This edition of the Innovation Partners BioBlog looks at cancer care in the era of COVID-19. ASCO released guidelines to help hospitals apportion scarce resources among critically ill patients, including cancer patients, during the pandemic. A new approach to prostate cancer drugs may delay drug

BioBlog

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 17
  • Go to Next Page »

EXPLORE OUR SERVICES

  • Payor and Market Access
  • Corporate and Patient Advocacy
  • Research and Forecasting
  • Healthcare Policy
  • Corporate Partnerships

BIOBLOG Curated News

COVID-19 Therapeutics and More

The U.S. Department of Justice gave the green light for six pharmaceutical companies to share manufacturing data in the quest for COVID-19 therapeutics. The companies may not, however, share pricing information and production costs. And changes are happening in the world of oncology from a new

Footer

Contact Innovation Partners

Together We're Better

Contact us for more information or to get started.

Don't See What You Need?

Customized services to meet your goals.

Join Our Panel

Compensated market research-seeking panelists.

© 2021 · Innovation Partners · Privacy Policy